REFERENCES
- Kesaniemi YA, Grundy SM. Dual eect in metabo-lism of very low density lipoprotein triglyceride. JAMA 1984; 251: 2542–7.
- Havel RJ, Kane JP, Kashyap ML. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 1973; 52: 32–8.
- Brunzell JD. Familial lipoprotein lipase deciency and other causes of the chylomicronemia syn- drome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995: 1913–32.
- Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M. Hypertriglyceridemia associated with deciency of apolipoprotein C-II. New Engl J Med 1978; 298: 1265–73.
- Kihara S, Matsuzawa Y, Kubo M, Nozaki S, Funahashi T, Yamashita A, Sho N, Tarui S. Autoimmune hyperchylomicronemia. New Engl J Med 1989; 320: 1255–9.
- Kobayashi J, Shirai K, Saito Y, Yoshida S. Lipoprotein lipase with a defect in lipid interface recognition in a case with type I hyperlipidemia. Eur J Clin Invest 1989; 19: 424–32.
- Matsuoka N, Shirai K, Johnson JD, Kashyap ML, Srivastava LS, Yamamura T, Yamamoto A, Saito Y, Kumagai A, Jackson RL. Eects of apolipopro- tein C-II (apoC-II) on the lipolysis of very low den-sity lipoproteins from apoC-II decient patients. Metabolism 1981; 30: 818–24.
- Belfrage P, Vaughan H. Simple liquid-liquid partition system for isolation of labeled oleic acid from mixture with glycerides. J Lipid Res 1969; 10: 341–4.
- Shirai K, Kobayashi J, Inadera H, OhkuboY,Mori S, Saito Y,Yoshida S. Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride. Metabolism 1992; 41: 1161–4.